Literature DB >> 30745046

The train has left: Can surgeons still get a ticket to treat structural heart disease?

Tom C Nguyen1, Gilbert H L Tang2, Stephanie Nguyen3, Jessica Forcillo4, Isaac George5, Tsuyoshi Kaneko6, Vinod H Thourani7, Joseph E Bavaria8, Anson W Cheung9, Michael J Reardon10, Michael J Mack11.   

Abstract

With the disruptive advancement of catheter-based technologies and minimally invasive techniques in structural heart disease, surgeons must obtain necessary skills to continue to serve this large patient population. We believe that surgeons are uniquely positioned to offer the full spectrum of therapy in structural heart disease (transcatheter, minimally invasive, and complex redo interventions), making them comprehensive valve specialists. Given the variability in structural heart training, we urgently recommend the establishment of a standardized curriculum and pathways for surgical trainees to gain proficiency in transcatheter technologies.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  endovascular; fellowship; minimally invasive; residency; standardized curriculum; structural heart disease; transcatheter

Year:  2019        PMID： 30745046     DOI： 10.1016/j.jtcvs.2019.01.011

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Cardiovascular Surgery Procedural Training and Evaluation: Current Status and Future Directions.

Authors:  Qasim Al Abri; Moritz C Wyler von Ballmoos
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-06-03

Review 2.  Current results and remaining challenges of trans-catheter aortic valve replacement expansion in intermediate and low risk patients.

Authors:  Alfonso Ielasi; Azeem Latib; Maurizio Tespili; Francesco Donatelli
Journal:  Int J Cardiol Heart Vasc       Date:  2019-05-15

3.  European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease.

Authors:  Simona Grozinsky-Glasberg; Joseph Davar; Johannes Hofland; Rebecca Dobson; Vikas Prasad; Andreas Pascher; Timm Denecke; Margot E T Tesselaar; Francesco Panzuto; Anders Albåge; Heidi M Connolly; Jean-Francois Obadia; Rachel Riechelmann; Christos Toumpanakis
Journal:  J Neuroendocrinol       Date:  2022-05-25       Impact factor: 3.870

4.  Racial Differences in the Use of Aortic Valve Replacement for Treatment of Symptomatic Severe Aortic Valve Stenosis in the Transcatheter Aortic Valve Replacement Era.

Authors:  J Matthew Brennan; Martin B Leon; Paige Sheridan; Isabel J Boero; Qinyu Chen; Angela Lowenstern; Vinod Thourani; Sreekanth Vemulapalli; Kevin Thomas; Tracy Y Wang; Eric D Peterson
Journal:  J Am Heart Assoc       Date:  2020-08-11       Impact factor: 5.501

5.  Commentary: Preaching to the wire.

Authors:  Hellmuth R Muller Moran; Michael H Yamashita
Journal:  JTCVS Tech       Date:  2020-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.